Dr. Nathan Goodyear - Ivermectin: A Game-Changer in Cancer Treatment?

Recent research underscores its potential as a formidable cancer therapeutic. Here’s why:
1. Pathway Inhibition: Blocks crucial WNT/β-Catenin pathways, halting cancer cell proliferation (Jin et al., 2020).
2. Apoptosis: Promotes programmed cell death in cancer cells, essential for treatment efficacy (Zhang et al., 2019).
3. Autophagy: Triggers cancer cell self-destruction from within, disrupting their survival (Dou et al., 2016).
4. Signal Disruption: Interferes with PAK1 and AKT/mTOR pathways, cutting off cancer cell communication (Wang et al., 2018).
5. Anti-angiogenesis: Prevents new blood vessel formation, starving tumors of their needed nutrients (Chiu et al., 2020).
6. Tumor Environment: Alters the tumor microenvironment to hinder cancer progression (Senyuk et al., 2019).
7. DNA Repair Inhibition: Impairs cancer cells’ ability to repair DNA, boosting their vulnerability to therapies (Zhu et al., 2017).
This could revolutionize our approach to cancer treatment.